Name | cevimeline |
---|---|
Synonyms |
3]oxathiolane]
CevimelineHClSalt CEVIMELINE, HYDROCHLORIDE SALT (2R,2'R)-2'-Methylspiro[4-azabicyclo[2.2.2]octane-2,5'-[1,3]oxathiolane] cis-2'-Methylspiro[4-azabicyclo[2.2.2]octane-2,5'-[1,3]oxathiolane] Evoxac AF-102B (2R,2'R)-2'-Methylspiro[4-azabicyclo[2.2.2]octan-2,5'-[1,3]oxathiolan] (2R,2'R)-Cevimeline Cevimeline (2R,2'R)-rel-2'-Methylspiro[4-azabicyclo[2.2.2]octane-2,5'-[1,3]oxathiolane] 3R)-rel Spiro[1-azabicyclo[2.2.2]octane-3,5'-[1,3]oxathiolane], 2'-methyl-, (2'R,3R)- SNI-2011 |
Description | Cevimeline (Evoxac) is a parasympathomimetic and muscarinic agonist, with particular effect on M3 receptors; used in the treatment of dry mouth associated with sjogren's syndrome.IC50 value:Target: M3 receptor |
---|---|
Related Catalog | |
References |
[4]. Voskoboynik B, et al.Cevimeline (Evoxac) overdose.J Med Toxicol. 2011 Mar;7(1):57-9. |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 308.5±42.0 °C at 760 mmHg |
Melting Point | 195-197ºC |
Molecular Formula | C10H17NOS |
Molecular Weight | 199.31 |
Flash Point | 140.4±27.9 °C |
PSA | 37.77000 |
LogP | 1.23 |
Vapour Pressure | 0.0±0.7 mmHg at 25°C |
Index of Refraction | 1.586 |
Storage condition | -20°C |